SG11202110845YA - Treatment of intervertebral disc degeneration - Google Patents

Treatment of intervertebral disc degeneration

Info

Publication number
SG11202110845YA
SG11202110845YA SG11202110845YA SG11202110845YA SG11202110845YA SG 11202110845Y A SG11202110845Y A SG 11202110845YA SG 11202110845Y A SG11202110845Y A SG 11202110845YA SG 11202110845Y A SG11202110845Y A SG 11202110845YA SG 11202110845Y A SG11202110845Y A SG 11202110845YA
Authority
SG
Singapore
Prior art keywords
treatment
intervertebral disc
disc degeneration
degeneration
intervertebral
Prior art date
Application number
SG11202110845YA
Inventor
Moon Noh
Hyun Bae
Sung Kang
Kwan Lee
Original Assignee
Kolon Tissuegene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kolon Tissuegene Inc filed Critical Kolon Tissuegene Inc
Publication of SG11202110845YA publication Critical patent/SG11202110845YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
SG11202110845YA 2019-03-29 2020-03-30 Treatment of intervertebral disc degeneration SG11202110845YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962826676P 2019-03-29 2019-03-29
PCT/US2020/025705 WO2020205730A1 (en) 2019-03-29 2020-03-30 Treatment of intervertebral disc degeneration

Publications (1)

Publication Number Publication Date
SG11202110845YA true SG11202110845YA (en) 2021-10-28

Family

ID=72667447

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202110845YA SG11202110845YA (en) 2019-03-29 2020-03-30 Treatment of intervertebral disc degeneration

Country Status (12)

Country Link
US (2) US20220160834A1 (en)
EP (1) EP3946381A4 (en)
JP (1) JP2022527849A (en)
KR (1) KR20220016809A (en)
CN (1) CN113924104A (en)
AU (1) AU2020252089A1 (en)
BR (1) BR112021019574A2 (en)
CA (1) CA3135603A1 (en)
IL (1) IL286805A (en)
MX (1) MX2021011951A (en)
SG (1) SG11202110845YA (en)
WO (1) WO2020205730A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115714024B (en) * 2022-11-22 2023-11-21 东南大学 Tissue fluid-fiber circulation solid coupling intervertebral disc soft tissue injury evolution prediction method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479066B1 (en) * 1999-12-16 2002-11-12 Rst Implanted Cell Technology, Llc Device having a microporous membrane lined deformable wall for implanting cell cultures
KR20110036696A (en) * 2008-03-21 2011-04-08 티슈진, 인코포레이티드 Treatment of intervertebral disc degeneration
EP2303290B1 (en) * 2008-06-25 2018-07-25 Mesoblast, Inc. Repair and/or reconstitution of invertebral discs
US20140099709A1 (en) * 2012-06-19 2014-04-10 Organovo, Inc. Engineered three-dimensional connective tissue constructs and methods of making the same
WO2015035395A1 (en) * 2013-09-09 2015-03-12 Figene, Llc Gene therapy for the regeneration of chondrocytes or cartilage type cells
WO2018135902A1 (en) * 2017-01-19 2018-07-26 가톨릭대학교 산학협력단 Method for producing cartilage cells induced to be differentiated from stem cells
WO2020205720A2 (en) * 2019-03-29 2020-10-08 Kolon Tissuegene, Inc. Mixed-cell gene therapy

Also Published As

Publication number Publication date
CA3135603A1 (en) 2020-10-08
KR20220016809A (en) 2022-02-10
CN113924104A (en) 2022-01-11
AU2020252089A1 (en) 2021-11-18
EP3946381A1 (en) 2022-02-09
WO2020205730A1 (en) 2020-10-08
MX2021011951A (en) 2022-01-04
US20210052664A1 (en) 2021-02-25
IL286805A (en) 2021-10-31
US20220160834A1 (en) 2022-05-26
BR112021019574A2 (en) 2021-12-21
EP3946381A4 (en) 2023-01-11
JP2022527849A (en) 2022-06-06

Similar Documents

Publication Publication Date Title
EP3474785A4 (en) Spinal implant and methods of using the same
EP3661441A4 (en) Spinal implant and method of manufacture
HK1250494A1 (en) Biocompatible implants for nerve re-generation and methods of use thereof
EP3182936A4 (en) Vertebral implants and related methods of use
EP3434291A4 (en) Composition for treating intervertebral disc
EP3188679A4 (en) Intervertebral implants and related methods of use
EP3531898A4 (en) Bone reconstruction implant
EP3630065A4 (en) Treatment of depressive disorders
IL287594A (en) Compositions and methods for the treatment of retinal degeneration
EP3496634A4 (en) Intervertebral implant
EP3787650A4 (en) Enhancement of fibroblast plasticity for treatment of disc degeneration
IL286805A (en) Treatment of intervertebral disc degeneration
EP3713521A4 (en) Spinal implant
EP3265165A4 (en) Implant applicators and methods of administering implants
IL257935A (en) Treatment of bone growth disorders
GB201616849D0 (en) Regneration of diseased intervertebral discs
EP3821835C0 (en) Spinal implant structure
EP4003399A4 (en) Methods of preventing or treating fatty degeneration of skeletal muscle
EP3710030A4 (en) Compositions and methods for treating intervertebral discs
GB201916428D0 (en) Treatment of hydro-carbon-contaminated materials
EP3856147A4 (en) Methods and probiotic compositions for the treatment of bone disorders
EP3723667A4 (en) Intervertebral prosthesis
EP3875092A4 (en) Composition for prevention or treatment of macular degeneration
EP3439691A4 (en) Methods and compositions for the treatment of intervertebral disc herniation
EP3691553A4 (en) Spinal implant